Cerus Corporation (CERS): Price and Financial Metrics
CERS Price/Volume Stats
| Current price | $1.58 | 52-week high | $2.59 |
| Prev. close | $1.58 | 52-week low | $1.38 |
| Day low | $1.55 | Volume | 2,375,400 |
| Day high | $1.64 | Avg. volume | 1,281,198 |
| 50-day MA | $1.74 | Dividend yield | N/A |
| 200-day MA | $1.88 | Market Cap | 293.43M |
CERS Stock Price Chart Interactive Chart >
Cerus Corporation (CERS) Company Bio
Cerus Corporation operates as a biomedical products company which focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The company was founded in 1991 and is based in Concord, California.
CERS Price Returns
| 1-mo | -5.39% |
| 3-mo | -12.22% |
| 6-mo | -6.51% |
| 1-year | -29.78% |
| 3-year | -77.10% |
| 5-year | -62.82% |
| YTD | -26.85% |
| 2023 | -40.82% |
| 2022 | -46.40% |
| 2021 | -1.59% |
| 2020 | 63.98% |
| 2019 | -16.77% |
Continue Researching CERS
Want to see what other sources are saying about Cerus Corp's financials and stock price? Try the links below:Cerus Corp (CERS) Stock Price | Nasdaq
Cerus Corp (CERS) Stock Quote, History and News - Yahoo Finance
Cerus Corp (CERS) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...